New Dry AMD Trial to be Starting Soon
Posted on March 31, 2022 by Pacific Northwest Retina in Age-Related Macular Degeneration
Research on age-related macular degeneration (AMD) is rapidly producing new candidate drugs. AMD patients may wish to consider participating in clinical trials. By doing this you could receive a treatment that may be more effective than currently available options, as well as help future generations of patients.
By doing this you could receive a treatment that may be more effective than currently available options, as well as help future generations of patients.
Pacific Northwest Retina is excited to announce a new dry AMD trial starting soon. For more information visit our Clinical Trials page.
